PATENT CLAIM ANALYSIS

Application Number: 15747136
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
Described herein are gene-activated fibrillar compositions and methods, processes, devices for the design, preparation, manufacture and/or formulation of thereof which are capable to encode at least one polypeptide of interest. Methods treating a disease, disorder and/or condition in a subject by increasing the level of at least one polypeptide of interest, by administering to said subject the gene-activated fibrillar composition are also disclosed.

Claim (Index 9):
A composition of  claim 1 , wherein the nucleic acids or nucleic acid based compounds modulate gene expression of the cells selected from the group consisting of hepatocytes, hematopoietic cells, epithelial cells, endothelial cells, lung cells, bone cells, stem cells, mesenchymal cells, neural cells, cardiac cells, adipocytes, vascular smooth muscle cells, cardiomyocytes, skeletal muscle cells, pancreatic beta cells, pituitary cells, synovial lining cells, ovarian cells, testicular cells, fibroblasts, B cells, T cells, reticulocytes, leukocytes, granulocytes and tumor cells.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.54348
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13925005', '14351128', '11464184', '12539563', '14369008']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.614090832394173
- 35 USC 102 Novelty (BERT): 0.4980453699967898
- Combined Prediction Score: 0.6024862861544347
- Mean Citation Score: 192.138298
- Max Citation Score: 220.22778
- Similarity Product: 140.58379696671724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test